Latest
Simply Wall St. Market update
Could Illuminaโs Novacyt Collaboration Framework Quietly Reshape Its Clinical Sequencing Narrative (ILMN)?
In September 2026, Novacyt S.A. announced it had entered into a five-year Master Collaboration Agreement with Illumina, creating a framework for separate project-based deals in product development and commercial collaboration. This structure gives Illumina a flexible way to tap Novacyt's complementary expertise without committing upfront capital to specific programs, potentially broadening future genomic applications. We'll now examine how โฆ
Main company
๐ซ๐ท France
Read at Simply Wall St.